🚀 MEDTL Medical Technologies Ltd is thrilled to announce that we have successfully secured a total of €3 million in funding.

This includes a €1.5 million grant from the Ίδρυμα Έρευνας και Καινοτομίας / Research and Innovation Foundation of Cyprus and €1.5 million from an international investment fund. This strategic funding will allow MEDTL to accelerate research and development, bring cutting-edge AI-powered solutions to market, and push the boundaries of cardiovascular healthcare innovation.

With this funding, MEDTL is set to expand its team of AI researchers, engineers, and medical experts, further enhancing the capabilities of our diagnostic platforms. Our goal is to deliver highly accurate, real-time cardiovascular insights that enable early detection, personalized care, and improved patient outcomes.

We are deeply grateful to all partners, supporters, and stakeholders who have contributed to our journey. Together, we continue to shape the future of heart health — where prevention, innovation, and AI-driven diagnostics save lives. ❤️